{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T03:03:48Z","timestamp":1779764628456,"version":"3.53.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CE_HE_CANCER21_RIA"],"award-info":[{"award-number":["CE_HE_CANCER21_RIA"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CE_H2020-SC1_20_2s04"],"award-info":[{"award-number":["CE_H2020-SC1_20_2s04"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CE_H2020-SC1_19_1s24"],"award-info":[{"award-number":["CE_H2020-SC1_19_1s24"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/01457 and PI23\/0692"],"award-info":[{"award-number":["PI22\/01457 and PI23\/0692"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"TV3 La Marat\u00f3 Foundation","doi-asserted-by":"publisher","award":["718\/C\/2019"],"award-info":[{"award-number":["718\/C\/2019"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:p>We describe a 54-year-old patient with xeroderma pigmentosum (XP) who developed unresectable cutaneous squamous cell carcinoma and was treated with pembrolizumab, an immune checkpoint inhibitor (ICI). The treatment led to significant tumour regression and, unexpectedly, a complete resolution of the patient\u2019s lentigines, while vitiligo and other pigmented lesions remained unchanged. The findings suggest that ICIs may amplify immune responses against ultraviolet-induced pigmented lesions in patients with XP, potentially linked to the disease\u2019s high mutational burden. Further studies are needed to elucidate the underlying mechanisms.<\/jats:p>","DOI":"10.1093\/ced\/llag029","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:42:43Z","timestamp":1768999363000},"page":"1101-1103","source":"Crossref","is-referenced-by-count":0,"title":["Pembrolizumab therapy leads to resolution of lentigines and tumour control in a patient with xeroderma pigmentosum and advanced cutaneous squamous cell carcinoma"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2510-4161","authenticated-orcid":false,"given":"Mag\u00ed","family":"Brufau-Cochs","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1394-4306","authenticated-orcid":false,"given":"Sofia","family":"G\u00f3mez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Aya","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]},{"name":"August Pi i Sunyer Biomedical Research Institute , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Serra-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]},{"name":"August Pi i Sunyer Biomedical Research Institute , Barcelona ,","place":["Spain"]},{"name":"Spanish Network for Rare Diseases, Carlos III Health Institute , Barcelona ,","place":["Spain"]},{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]},{"name":"August Pi i Sunyer Biomedical Research Institute , Barcelona ,","place":["Spain"]},{"name":"Spanish Network for Rare Diseases, Carlos III Health Institute , Barcelona ,","place":["Spain"]},{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Podlipnik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Clinic Barcelona , Barcelona ,","place":["Spain"]},{"name":"August Pi i Sunyer Biomedical Research Institute , Barcelona ,","place":["Spain"]},{"name":"Spanish Network for Rare Diseases, Carlos III Health Institute , Barcelona ,","place":["Spain"]},{"name":"Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026052522570101400_llag029-B1","doi-asserted-by":"crossref","first-page":"1282823","DOI":"10.3389\/fonc.2023.1282823","article-title":"Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers","volume":"13","author":"Fernandez","year":"2023","journal-title":"Front Oncol"},{"key":"2026052522570101400_llag029-B2","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1111\/jdv.14678","article-title":"Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1","volume":"32","author":"Thomas","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026052522570101400_llag029-B3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bjd.16270","article-title":"Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum","volume":"178","author":"Salomon","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026052522570101400_llag029-B4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2017.06.022","article-title":"Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: case report and review of the literature","volume":"83","author":"Deinlein","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026052522570101400_llag029-B5","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/jdv.14818","article-title":"Reversed actinic \u00addamage in two children with xeroderma pigmentosum treated with topical imiquimod","volume":"32","author":"Latour","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag029\/66551236\/llag029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/6\/1101\/66551236\/llag029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/6\/1101\/66551236\/llag029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:57:10Z","timestamp":1779764230000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/6\/1101\/8439112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":5,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llag029","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,1,22]]}}}